Is a Positive NECPAL in ICU Patients Associated With Higher Mortality
ConditionAcute Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age75+
SponsorConsorci Sanitari de l'Alt Penedès i Garraf
About this trial
The aim of the present study is to evaluate the usefulness of the NECPAL scale in identifying Intensive Care Unit (ICU)-admitted patients at higher risk of dying within 90 days of ICU admission
Eligibility criteria
Qualifiers
Men and women aged 75 years or older.
Admission to the ICU of the study center.
Legal capacity to provide informed consent.
Signed informed consent for study inclusion, either by the participant or their legal representative.
Disqualifiers
None
Trial design
Treatments tested in this trial
- NECPAL positive
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov